Denali Therapeutics Inc. (DNLI) PT Raised to $41 at Stifel

March 25, 2026 4:13 PM

Stifel analyst Paul Mattels raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $41.00 (from $34.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found